Want to see JP:4889 full AI Analyst Report?
Renascience Inc. (4889) Financial Statements
Renascience Inc. Financial Overview
Renascience Inc.'s market cap is currently $13.38B. The company's EPS TTM is $-24.08; its P/E ratio is -40.32; Renascience Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 68.55M | $ 132.69M | $ 194.16M | $ 100.55M | $ 139.33M |
| Gross Profit | $ 64.21M | $ 128.95M | $ 165.64M | $ 100.30M | $ 77.60M |
| Operating Income | $ -356.88M | $ -178.83M | $ -252.34M | $ -333.87M | $ -210.84M |
| EBITDA | $ -356.88M | $ 143.82M | $ -250.50M | $ -332.49M | $ -244.65M |
| Net Income | $ -301.28M | $ 113.43M | $ -258.33M | $ -335.80M | $ -254.29M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.40B | $ 1.80B | $ 2.03B | $ 2.21B | $ 2.39B |
| Total Assets | $ 3.50B | $ 1.87B | $ 2.09B | $ 2.27B | $ 2.44B |
| Total Debt | $ 0.00 | $ 0.00 | $ 356.10M | $ 309.60M | $ 199.23M |
| Net Debt | $ -3.40B | $ -1.80B | $ -1.67B | $ -1.90B | $ -2.19B |
| Total Liabilities | $ 180.59M | $ 151.21M | $ 482.11M | $ 409.76M | $ 237.17M |
| Stockholders' Equity | $ 3.32B | $ 1.72B | $ 1.61B | $ 1.87B | $ 2.20B |
| Cash Flow | |||||
| Free Cash Flow | $ -291.31M | $ -177.14M | $ -232.10M | $ -286.87M | $ -231.66M |
| Operating Cash Flow | $ -291.31M | $ -176.34M | $ -230.52M | $ -284.64M | $ -230.49M |
| Investing Cash Flow | $ 0.00 | $ 382.15M | $ -1.57M | $ 232.00K | $ -296.00K |
| Financing Cash Flow | $ 1.89B | $ -52.18M | $ 46.50M | $ 110.37M | $ 1.59B |
Currency in JPY